Fairmount Funds Management LLC Portfolio Holdings

Fairmount Funds Management LLC

  • $628 Million
  • Q1 2024

Fairmount Funds Management LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $628 Million distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Axsome Therapeutics, Inc. with a value of $188M, Nuvalent, Inc. with a value of $145M, Kiniksa Pharmaceuticals, Ltd. with a value of $63.2M, Astria Therapeutics, Inc. with a value of $50M, and Merus N.V. with a value of $32.3M.

Examining the 13F form we can see an decrease of $101M in the current position value, from $729M to 628M.

Fairmount Funds Management LLC is based out at Philadelphia, PA

Below you can find more details about Fairmount Funds Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $628 Million
Healthcare: $628 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.15B
$188 Million 30.01% of portfolio
2,360,077
Q4 2023 Added 0.8%
$2.82B
$145 Million 23.03% of portfolio
1,924,626
Q4 2023 Reduced 21.5%
$655M
$63.2 Million 10.07% of portfolio
3,204,841
Q1 2024 Added 11.15%
$144M
$50 Million 7.97% of portfolio
3,554,129
Q4 2023 Added 86.92%
$2.44B
$32.3 Million 5.15% of portfolio
717,254
Q4 2023 Reduced 61.88%
$477M
$32.3 Million 5.15% of portfolio
1,845,813
Q1 2024 Added 34.77%
$527M
$31.8 Million 5.06% of portfolio
4,725,641
Q1 2024 Added 32.78%
$1.38B
$27 Million 4.3% of portfolio
931,890
Q1 2024 New
$681M
$22.9 Million 3.64% of portfolio
1,393,329
Q3 2023 Reduced 1.67%
$1.34B
$22 Million 3.51% of portfolio
6,666,667
Q1 2024 New
$226M
$13.4 Million 2.13% of portfolio
2,040,000
Q4 2022 Reduced 0.49%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 50.27%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 43.26%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 30.35%

Summary

  • Portfolio
  • No. of Stocks 15
  • Current Value $628 Million
  • Prior Value $729 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 2 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email